Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China

Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise significantly during hospitalization and no patients experienced liver failure, however. Kenneth Sherman, MD, PhD, Director of the UC Division of Digestive Diseases and UC Health physician, spoke with journalist Marilynn Larkin about possible liver damage associated with SARS-CoV-2 and how pre-existing liver disease could make individuals more susceptible to infection leading to COVID-19.

Read the entire interview online.

Learn more about Sherman’s COVID-19 research.

/University Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.